Ekso Bionics Holdings Inc

General ticker "EKSO" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $13.4M

Ekso Bionics Holdings Inc does not follow the US Stock Market performance with the rate: -41.3%.

Estimated limits based on current volatility of 6.9%: low 0.59$, high 0.68$

Factors to consider:

  • Current price 43.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.06$, 3.13$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.57$, 4.09$]

Financial Metrics affecting the EKSO estimates:

  • Negative: Non-GAAP EPS, $ of -1.10 <= 0.10
  • Negative: Operating profit margin, % of -45.26 <= 1.03
  • Negative: Operating cash flow per share per price, % of -36.04 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term EKSO quotes

Long-term EKSO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $11.25MM $12.91MM $18.28MM
Operating Expenses $25.07MM $28.47MM $33.39MM
Operating Income $-13.83MM $-15.56MM $-15.11MM
Non-Operating Income $4.06MM $0.48MM $-0.50MM
Interest Expense $0.11MM $0.16MM $0.30MM
R&D Expense $2.75MM $3.63MM $5.03MM
Income(Loss) $-9.76MM $-15.08MM $-15.61MM
Profit(Loss) $-9.76MM $-15.08MM $-15.61MM
Stockholders Equity $37.22MM $25.44MM $12.61MM
Assets $49.17MM $40.90MM $28.92MM
Operating Cash Flow $-11.16MM $-14.69MM $-12.05MM
Capital expenditure $0.06MM $0.19MM $0.16MM
Investing Cash Flow $-0.06MM $-5.17MM $-0.16MM
Financing Cash Flow $38.71MM $0.00MM $0.35MM
Earnings Per Share* $-0.69 $-1.13 $-1.10

* EPS are Split Adjusted, recent splits may be reflected with a delay.